Suviray Injection
Marketer
Novartis India Ltd
Salt Composition
Erenumab (70mg/ml)
Overview Suviray Injection
Erenumab (Suviray Injection) is a medication that blocks CGRP receptors, a protein believed to trigger migraine headaches. Approved for adult migraine prevention, it's administered via subcutaneous injection into the abdomen, thigh, or upper arm. Allow the pre-filled syringe to reach room temperature (at least 30 minutes) away from direct sunlight; avoid artificial warming methods like hot water or microwaves. Injection sites should be free of bruising, tenderness, or hardened areas. Common side effects include injection site reactions (pain, swelling, redness), and constipation; less frequent side effects may include itching and muscle spasms. Report persistent or worsening side effects to your physician for potential management options. This medication is contraindicated in individuals with erenumab allergy or hypersensitivity to any of its components. Consult your physician before use, disclosing all medical conditions, including pregnancy, pregnancy planning, or breastfeeding.
Uses of Suviray Injection
Migraine Prevention Strategies
Major Benefits of Suviray Injection:
Medical staff will instruct you on the proper administration of this medication.
Common Side effects of Suviray Injection:
- Injection site reactions (pain, swelling, redness)
- Constipation
- Itching
How to use Suviray Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Suviray Injection works:
Suviray Injection is a human-derived monoclonal antibody that neutralizes the activity of the calcitonin gene-related peptide (CGRP) receptor by directly binding to it.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Suviray Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Suviray Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Suviray Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Suviray Injection.
KidneySAFE IF PRESCRIBED
Suviray Injection appears to be well-tolerated in individuals with kidney impairment. Preliminary evidence indicates dose modification for Suviray Injection may be unnecessary in this population; however, medical advice is recommended.
LiverSAFE IF PRESCRIBED
Suviray Injection appears safe for use in individuals with hepatic impairment. Available evidence indicates dose modification for Suviray Injection may be unnecessary in this population. Physician consultation is recommended.
What if you forget to take Suviray Injection :
Should you forget a Suviray Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Suviray Injection
| Label | Value |
|---|---|
| Chemical Classification | Short amino acid chains |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Behavioral Class | Monoclonal antibody therapy |
3,018 People bought this recently